| Please plan to arrive 20 minutes before the first session to get through security and walk over to the Natcher Conference Center. |
| Monday, April 15, 2013 |
| 8:00 a.m. |
Welcome Griffin Rodgers, M.D., M.A.C.P., Director, National Institute of Diabetes and Digestive and Kidney Diseases |
| 8:10 a.m. |
Keynote Address: Beta Cell Dedifferentiation and Plasticity in Diabetes Domenico Accili |
| |
| Session I: Inter-islet Communication: Nerves, Neurotransmitters, Vasculature, and Cell-cell Interactions |
| 8:40 a.m. |
Keynote: Role of Nerves in the Islet Alejandro Caicedo |
| 9:10 a.m. |
Discussion (with leader) |
| 9:20 a.m. |
Invited Talk: Autocrine and Paracrine Regulation of Islet Cell Function Patrik Rorsman |
| 9:50 a.m. |
Discussion (with leader) |
| 10:00 a.m. |
Break |
| 10:20 a.m. |
Invited Talk: Cell-cell and Vascular-cell Interactions in the Islet Eckhard Lammert |
| 10:50 a.m. |
Discussion (with leader) |
| 11:00 a.m. |
Submitted Talk: CT Perfusion Monitoring of the Pancreas in Streptozotocin-induced Diabetic Rats Joo Ho Tai |
| 11:15 a.m. |
Submitted Talk: Gadolinium-enhanced MRI of the Pancreatic Extracellular Volume to Detect Immune Infiltration Preceding Development of Type 1 Diabetes Mellitus in Mice Patrick F. Antkowiak |
| 11:30 a.m. |
Submitted Talk: Quantification of Pancreatic VMAT2 Binding Using (18F)FP-(+)-DTBZ in Human PET Studies: Optimization of Methods Mika Naganawa |
| 11:45 a.m. |
Submitted Talk: Functional Role of Dopamine Type 2 Receptors (D2R) and Vesicular Monoamine Transporter Type 2 (VMAT2) in Glucose Stimulated Insulin Secretion (GSIS) by Human Islets Paul Harris |
| 12:05 p.m. |
European Efforts, European Association for the Study of Diabetes Metabolic Imaging Study Group Martin Gotthardt |
| 12:15 p.m. |
Lunch (on your own) and Poster Session There will be two informal, open discussions starting at 2:15 p.m., which will be held among the posters.
- DTBZ Ligands and the VMAT2 Target
- GLP-1 Receptor Targeting
|
| |
|
|
Session II: Imaging Islet Function and Mass |
| 3:00 p.m. |
Chair’s Introduction: Zn imaging of Insulin Secretion Dean Sherry |
| 3:20 p.m. |
Keynote: Challenges and Opportunities in Beta Cell Imaging Al Powers |
| 3:50 p.m. |
Discussion (with leader) |
| 4:00 p.m. |
Invited Talk Guy Rutter |
| 4:20 p.m. |
Discussion (with leader) |
| 4:30 p.m. |
Break |
| 4:50 p.m. |
Invited Talk: Manganese-enhanced Magnetic Resonance Imaging (MEMRI) of Pancreatic Islets, and Multivalent Targeting of Beta Cells Paolo Meda |
| 5:20 p.m. |
Discussion (with leader) |
| 5:30 p.m. |
Submitted Talk: Quantitative Pathophysiological Analyses of the Whole Human Pancreas Manami Hara |
| 5:45 p.m. |
Submitted Talk: Introducing a Novel FRET Biosensor for Glycolytic Activity: Islet Beta Cell Glycolytic and Mitochondial Function Measured Simultaneously and in Real Time Matthew J. Merrins |
| 6:00 p.m. |
Submitted Talk: Application of a Novel GLP-1 Analogue for GLP-1R Targeted Imaging in Ossabaw Mini Pigs: Initial Result William Silvers |
| 6:15 p.m. |
Submitted Talk: A Heterobivalent Ligand Comprised of GLP-1 and Yohimbine Specifically Targets Pancreatic β-Cells In Vivo Sean W. Limesand |
| 6:30 p.m. |
Adjournment |
| |
|
| Tuesday, April 16, 2013 |
| 8:00 a.m. |
Industry Perspective: Imaging Biomarker Needs for Preclinical Development and Clinical Trials in Diabetes Melissa Thomas, Lily Pharmaceuticals |
| |
|
| Session III: Beta Cell Markers and Search for Targeting Agents |
| 8:20 a.m. |
Chair’s Introduction Markus Grompe |
| 8:30 a.m. |
Keynote: Clinical and Practical Applications of Beta-cell Imaging David Harlan |
| 9:00 a.m. |
Discussion (with leader) |
| 9:10 a.m. |
Invited Talk: Toward Islet Cell Specific Reagents Phil Streeter |
| 9:40 a.m. |
Discussion (with leader) |
| 9:50 a.m. |
Break |
| 10:10 a.m. |
Invited Talk: Radiopharmaceutical Development Mark Mintun, Avid Radiopharmaceuticals |
| 10:30 a.m. |
Discussion (with leader) |
| 10:40 a.m. |
Submitted Talk: Exendin-4 Loaded Magnetic Iron Nanoparticles for Pancreatic Islet Imaging Ping Wang |
| 10:55 a.m. |
Submitted Talk: Non-invasive Determination of the Beta Cell Mass by SPECT With 111In-DTPA-exendin-3 in a Rat Model for Spontaneous Type 1 Diabetes Maarten Brom |
| 11:10 a.m. |
Submitted Talk: Preparation of Beta-cell Targeted Magnetic Nanoparticle With Sphingomyelin Specificity Amol Kavishwar |
| 11:25 a.m. |
Submitted Talk: Imaging With Aptamers Giacomo Lanzoni |
| 1:40 a.m. |
EC Perspective Nathalie Vercruysse |
| 11:50 a.m. |
Lunch and Poster Session |
| |
|
| Session IV: Transplantation and Immunology, Including Cell Therapies |
| 1:30 p.m. |
Chair’s Introduction Olle Korsgren |
| 1:40 p.m. |
Keynote: Imaging Beta Cell Mass Olof Eriksson |
| 2:10 p.m. |
Discussion (with leader) |
| 2:20 p.m. |
Invited Talk: Imaging the T1D Pancreas: Anatomy, Beta Cell Mass, and Inflammation Jason Gaglia |
| 2:50 p.m. |
Discussion (with leader) |
| 3:00 p.m. |
Break |
| 3:20 p.m. |
Invited Talk: Insulitis and Islet Volume in the Non-obese Diabetic (NOD) Mouse Dan Holmberg |
| 3:50 p.m. |
Discussion (with leader) |
| 4:00 p.m. |
Submitted Talk: High-resolution In Vivo Imaging of Transplanted Pancreatic Islets Reveals Complex Behavior of Innate Immune Cells in Engraftment Gustaf Christoffersson |
| 4:15 p.m. |
Submitted Talk: Dynamic Contrast Enhanced-MRI (DCE-MRI) Functional Assessment of Vascular Events Occurring During the Intra-hepatic Engraftment of Pancreatic Islets May Predict Long-term Outcome of Islets Transplantation Anna Palmisano |
| 4:30 p.m. |
Submitted Talk: Effect of Mesenchymal Stem Cells on the Vascularization of the Artificial Cavity Used as a Site for Islet Transplantation Daniel Jirak |
| 4:45 p.m. |
Summation and Discussion Chairs |
| 5:00 p.m. |
Adjournment |
| |
|